La Jolla biotech raises $63 million to make cancer drugs from artificial DNA


Kristine San Jose, research associate at Synthorx, is working on creating improved protein therapeutics from DNA that contains the synthetic base pair, X and Y. Kristine San Jose, research associate at Synthorx, is working on creating improved protein therapeutics from DNA that contains the synthetic base pair, X and Y. La Jolla's Synthorx has raised $63 million to make cancer drugs from a partly artificial life form, the biotech startup said Monday. The organism's unnatural DNA allows it to make improved forms of natural cancer-fighting proteins, Synthorx says.



from Biotech News